Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "histamine receptor pathway" is not a canonical name for a single molecular target but refers collectively to the signaling pathways mediated by four distinct histamine receptors—**Histamine H1**, **H2**, **H3**, and **H4**. Each is a G protein-coupled receptor that binds histamine as its endogenous ligand. These receptors are involved in diverse physiological processes: * The Histamine H1 Receptor mediates allergic responses such as smooth muscle contraction, increased vascular permeability leading to edema, sensory nerve stimulation causing itching/pain; it is targeted by classic antihistamines[1][7]. * The Histamine H2 Receptor regulates gastric acid secretion in parietal cells; antagonists are used for conditions like GERD[1]. * The Histamine H3 Receptor modulates neurotransmitter release within the central nervous system and is being explored as a target for neurological/psychiatric conditions[1][8]. * The Histamine H4 Receptor plays roles in immune cell chemotaxis and cytokine production; it has been implicated as a therapeutic target in inflammatory diseases such as atopic dermatitis and asthma[5]. All four are members of the GPCR superfamily but differ significantly in tissue distribution, signaling mechanisms, pharmacology, and clinical relevance. Drugs targeting these receptors include various generations of antihistamines for allergies/H1 blockade; proton pump inhibitors/H2 blockers for gastric issues; experimental agents modulating CNS function/H3 activity; anti-inflammatory compounds under investigation/H4 antagonists. Note on correctness ("is_incorrect"): The entry "histamine receptor pathway" does not refer to an individual molecule or canonical drug target but rather encompasses multiple related targets—the four known histamine receptors—each with distinct biological roles. For structured data purposes focused on molecular targets/receptors suitable for drug development pipelines or databases: *This entry should be flagged as incorrect ("is_incorrect": true), because it lacks specificity—it should be replaced by one or more entries corresponding to each individual histamine receptor subtype.*[1][4]
Blockade or inverse agonism of histamine receptors to reduce allergic symptoms or gastric acid secretion. Modulation of neurotransmitter release in the CNS for cognitive/sleep disorders via the H3 subtype. Inhibition of immune cell chemotaxis/inflammation via the H4 subtype.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histamine receptor pathway.